GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coegin Pharma (NGM:COEGIN) » Definitions » EBITDA Margin %

Coegin Pharma (NGM:COEGIN) EBITDA Margin % : 0.00% (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Coegin Pharma EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Coegin Pharma's EBITDA for the three months ended in Dec. 2024 was kr-6.24 Mil. Coegin Pharma's Revenue for the three months ended in Dec. 2024 was kr0.00 Mil. Therefore, Coegin Pharma's EBITDA margin for the quarter that ended in Dec. 2024 was 0.00%.


Coegin Pharma EBITDA Margin % Historical Data

The historical data trend for Coegin Pharma's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coegin Pharma EBITDA Margin % Chart

Coegin Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial - - - - -

Coegin Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Coegin Pharma's EBITDA Margin %

For the Biotechnology subindustry, Coegin Pharma's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coegin Pharma's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coegin Pharma's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Coegin Pharma's EBITDA Margin % falls into.


;
;

Coegin Pharma EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Coegin Pharma's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-20.162/0
= %

Coegin Pharma's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-6.243/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coegin Pharma  (NGM:COEGIN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Coegin Pharma EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Coegin Pharma's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Coegin Pharma Business Description

Traded in Other Exchanges
N/A
Address
c/o Medicon Village, Lund, SWE, 223 81
Coegin Pharma AB is a biotechnology company that focuses on the development of small molecule therapies for the treatment of inflammatory diseases such as cancer and kidney disease.

Coegin Pharma Headlines

No Headlines